Literature DB >> 7490328

A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas.

S Detre1, G Saclani Jotti, M Dowsett.   

Abstract

Immunohistochemistry is increasingly used in the assessment of markers for breast cancer prognosis. Semiquantitation is frequently desirable but, other than by the use of image analysis, the approaches currently in use are cumbersome. The most common method used is the H-score which takes into consideration the staining intensity in conjunction with the percentage of cells staining positively in breast carcinoma tissue. A "quickscore" has been developed which dispenses with the need to count individual cells. The quantitative biochemical Abbott enzyme immunoassay (EIA) and the Dako immunohistochemical assay (IHA) incorporating a semiquantitative H-score, have been used as standards against which the IHA quickscore for the semiquantitation of oestrogen receptor expression was tested. A good correlation was found between the quickscore and the EIA, which was as good as that between the H-score and EIA. The quickscore is a valid approach and there is no advantage in using the more rigorous H-score. A positive cut off quickscore of > or = 3 has been suggested.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7490328      PMCID: PMC502883          DOI: 10.1136/jcp.48.9.876

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  Relationship between radioligand binding assay, immunoenzyme assay and immunohistochemical assay for estrogen receptors in human breast cancer and association with tumor differentiation.

Authors:  J Andersen; S M Bentzen; H S Poulsen
Journal:  Eur J Cancer Clin Oncol       Date:  1988-03

2.  Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer.

Authors:  R A McClelland; P Finlay; K J Walker; D Nicholson; J F Robertson; R W Blamey; R I Nicholson
Journal:  Cancer Res       Date:  1990-06-15       Impact factor: 12.701

3.  Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis?

Authors:  D M Barnes; E A Dublin; C J Fisher; D A Levison; R R Millis
Journal:  Hum Pathol       Date:  1993-05       Impact factor: 3.466

4.  Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay.

Authors:  G Saccani Jotti; S R Johnston; J Salter; S Detre; M Dowsett
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

Review 5.  Determination of estrogen receptors in paraffin-embedded tissue. Techniques and the value in breast cancer treatment.

Authors:  J Andersen
Journal:  Acta Oncol       Date:  1992       Impact factor: 4.089

6.  Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods.

Authors:  L B Kinsel; E Szabo; G L Greene; J Konrath; G S Leight; K S McCarty
Journal:  Cancer Res       Date:  1989-02-15       Impact factor: 12.701

  6 in total
  318 in total

1.  Absence of Metallothionein 3 Expression in Breast Cancer is a Rare, But Favorable Marker of Outcome that is Under Epigenetic Control.

Authors:  Seema Somji; Scott H Garrett; Xu Dong Zhou; Yun Zheng; Donald A Sens; Mary Ann Sens
Journal:  Toxicol Environ Chem       Date:  2010-10       Impact factor: 1.437

2.  Immunoexpression of Steroid Hormone Receptors and Proliferation Markers in Uterine Leiomyoma and Normal Myometrial Tissues from the Miniature Pig, Sus scrofa.

Authors:  Kristie Mozzachio; Alicia B Moore; Grace E Kissling; Darlene Dixon
Journal:  Toxicol Pathol       Date:  2015-12-20       Impact factor: 1.902

3.  Biomarker analyses from a placebo-controlled phase II study evaluating erlotinib±onartuzumab in advanced non-small cell lung cancer: MET expression levels are predictive of patient benefit.

Authors:  Hartmut Koeppen; Wei Yu; Jiping Zha; Ajay Pandita; Elicia Penuel; Linda Rangell; Rajiv Raja; Sankar Mohan; Rajesh Patel; Rupal Desai; Ling Fu; An Do; Vaishali Parab; Xiaoling Xia; Tom Januario; Sharianne G Louie; Ellen Filvaroff; David S Shames; Ignacio Wistuba; Marina Lipkind; Jenny Huang; Mirella Lazarov; Vanitha Ramakrishnan; Lukas Amler; See-Chun Phan; Premal Patel; Amy Peterson; Robert L Yauch
Journal:  Clin Cancer Res       Date:  2014-03-31       Impact factor: 12.531

4.  PTOV1 is overexpressed in human high-grade malignant tumors.

Authors:  Sara Fernández; Jose L Mosquera; Lide Alaña; Alex Sanchez-Pla; Juan Morote; Santiago Ramón Y Cajal; Jaume Reventós; Inés de Torres; Rosanna Paciucci
Journal:  Virchows Arch       Date:  2010-12-23       Impact factor: 4.064

5.  MiR-200c suppresses the migration of retinoblastoma cells by reversing epithelial mesenchymal transition.

Authors:  Xiao-Lei Shao; Yao Chen; Ling Gao
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

6.  A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer?

Authors:  Alireza Mirzaei; Gholamreza Tavoosidana; Afshin Abdi Rad; Farhad Rezaei; Masoumeh Tavakoli-Yaraki; Azade Amini Kadijani; Ehsan Khalili; Zahra Madjd
Journal:  Tumour Biol       Date:  2015-09-17

7.  Fibulin-2 is involved in early extracellular matrix development of the outgrowing mouse mammary epithelium.

Authors:  D Olijnyk; A M Ibrahim; R K Ferrier; T Tsuda; M-L Chu; B A Gusterson; T Stein; J S Morris
Journal:  Cell Mol Life Sci       Date:  2014-02-13       Impact factor: 9.261

8.  Epistatic SNP interaction of ERCC6 with ERCC8 and their joint protein expression contribute to gastric cancer/atrophic gastritis risk.

Authors:  Jing-Jing Jing; You-Zhu Lu; Li-Ping Sun; Jing-Wei Liu; Yue-Hua Gong; Qian Xu; Nan-Nan Dong; Yuan Yuan
Journal:  Oncotarget       Date:  2017-06-27

9.  Downregulation of nuclear expression of the p33(ING1b) inhibitor of growth protein in invasive carcinoma of the breast.

Authors:  G S Nouman; J J Anderson; S Crosier; J Shrimankar; J Lunec; B Angus
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

10.  Estrogen receptor alpha (ERalpha) phospho-serine-118 is highly expressed in human uterine leiomyomas compared to matched myometrium.

Authors:  Tonia L Hermon; Alicia B Moore; Linda Yu; Grace E Kissling; Frank J Castora; Darlene Dixon
Journal:  Virchows Arch       Date:  2008-10-14       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.